Form 4 Tracker
Eric Venker

Director, Chief Executive Officer; President & Immunovant CEO · 14 filings · Latest: Oct 1, 2026

Immunovant, Inc.
Roivant Sciences Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ROIV
Eric VenkerPresident & Immunovant CEOApr 20, 2026
Option Exercise
$3.85200,000$770.0K1,847,546
ROIV
Venker Eric—Apr 20, 2026
Proposed Sale
$29.59200,000$5.9M—
IMVT
Eric VenkerDirector, Chief Executive OfficerApr 2, 2026
Sale
$24.1014,229$342.9K19,561
IMVT
Eric VenkerDirector, Chief Executive OfficerApr 1, 2026
Option Exercise
$14.46368,750$5.3M368,750
ROIV
Eric VenkerPresident & Immunovant CEOMar 17, 2026
Sale
$28.24200,000$5.6M1,647,546
ROIV
Eric VenkerPresident & Immunovant CEOMar 17, 2026
Option Exercise
$3.85200,000$770.0K1,847,546
ROIV
Venker Eric—Mar 17, 2026
Proposed Sale
$28.24200,000$5.6M—
ROIV
Eric VenkerPresident & Immunovant CEOFeb 13, 2026
Sale
$26.49200,000$5.3M1,654,597
ROIV
Eric VenkerPresident & Immunovant CEOFeb 13, 2026
Option Exercise
$3.85200,000$770.0K1,854,597
ROIV
Venker Eric—Feb 13, 2026
Proposed Sale
$26.49200,000$5.3M—
ROIV
Venker Eric—Jan 12, 2026
Proposed Sale
$21.92200,000$4.4M—
ROIV
ERIC VENKER—Dec 24, 2025
Proposed Sale
$22.5375,000$1.7M—
ROIV
ERIC VENKER—Dec 23, 2025
Proposed Sale
$22.45200,000$4.5M—
ROIV
Venker Eric—Dec 9, 2025
Proposed Sale
$20.85200,000$4.2M—
ROIV
Venker Eric—Nov 7, 2025
Proposed Sale
$20.22200,000$4.0M—
ROIV
Venker Eric—Oct 17, 2025
Proposed Sale
$17.06118,418$2.0M—
ROIV
Venker Eric—Oct 16, 2025
Proposed Sale
$17.05318,282$5.4M—
ROIV
Venker Eric—Oct 15, 2025
Proposed Sale
$16.93414,683$7.0M—
ROIV
Venker Eric—Oct 13, 2025
Proposed Sale
$16.2520,727$336.9K—
ROIV
Venker Eric—Oct 9, 2025
Proposed Sale
$16.30104,940$1.7M—